Amlogenyx Inc

Amlogenyx Inc. conducts biotechnology research focused on therapies for neurodegenerative diseases. The Company performs preclinical studies on protease therapy to reduce amyloid accumulation, develops gene therapies for Alzheimer's disease, and manufactures AAV gene therapy platforms. Amlogenyx Inc serves patients in the United States.